News Results

There are 628,362 News Results

Jun 11, 2017
INVOKANA® (canagliflozin) Significantly Reduces the Combined Risk of Cardiovascular Death, Myocardial Infarction and Stroke in the CANVAS Program
RARITAN, NJ and SAN DIEGO, June 12, 2017 /PRNewswire/ -- Results from the landmark CANVAS Program showed INVOKANA
Jun 13, 2017
Leju Reports First Quarter 2017 Results
BEIJING, June 14, 2017 /PRNewswire/ -- Leju Holdings Limited ("Leju" or the "Company") (NYSE: LEJU), a leading online-to-offline ("O2O") real estate services provider in China, today announced its unaudited financial...
Jun 13, 2017
New Phase 3 Data Show Anti-TNF Alpha SIMPONI ARIA® (golimumab) Significantly Improved Arthritis And Skin Manifestations In Patients With Active Psoriatic Arthritis
MADRID, June 14, 2017 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today results from the pivotal Phase 3 GO-VIBRANT study that showed the significant efficacy of the intravenously...
Jun 15, 2017
DARZALEX® (daratumumab) Approved by the U.S. FDA in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Who Have Received At Least Two Prior Therapies
HORSHAM, Pa., June 16, 2017 /PRNewswire/ -- Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the immunotherapy DARZALEX(® )(daratumumab) in combination with pomalidomide...
Jun 18, 2017
Pattern Energy Announces Key Strategic Initiatives for Major Expansion of Growth and Capital Opportunities with Pattern Development, Riverstone and PSP Investments
SAN FRANCISCO, and NEW YORK, and MONTRÉAL, June 19, 2017 /PRNewswire/ -- Pattern Energy Group Inc. (NASDAQ and TSX: PEGI) ("Pattern Energy" or the "Company"), Pattern Energy Group LP ("Pattern...
Jun 19, 2017
Shire plc: U.S. FDA Approves Mydayis[TM] (Mixed Salts of a Single-Entity Amphetamine Product) - A New Once-Daily Option for ADHD Symptom Control in Patients 13 Years and Older
LEXINGTON, Massachusetts, June 20, 2017 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S. Food and Drug Administration (FDA) has approved MYDAYIS[TM] (mixed salts of a...
Jun 21, 2017
Novartis combination targeted therapy Tafinlar® + Mekinist® receives FDA approval for BRAF V600E mutant metastatic non-small cell lung cancer (NSCLC)
EAST HANOVER, N.J., June 22, 2017 /PRNewswire/ -- Novartis today announced the US Food and Drug Administration (FDA) approval of Tafinlar(®) (dabrafenib) in combination with Mekinist(®) (trametinib) to treat patients...
Jun 27, 2017
U.S. FDA Grants Priority Review of XARELTO® (rivaroxaban) sNDA for a 10 mg Dose to Reduce the Risk of Recurrent Venous Thromboembolism (VTE)
RARITAN, N.J., June 28, 2017
Jul 5, 2017
Endo Provides Update On OPANA® ER
DUBLIN, July 6, 2017 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) continues to believe in the safety, efficacy, and favorable benefit-risk profile of OPANA(®) ER (oxymorphone hydrochloride extended release) when...
Jul 19, 2017
SAP Raises Outlook - Q2 Total Revenue Up Double-Digit
WALLDORF, Germany, July 20, 2017 /PRNewswire/ -- SAP SE (NYSE: SAP) today announced its financial results for the second quarter 2017 ended June 30, 2017. "This strong quarter is the...
62837

Pages

1

Stories of the day

Jun 16, 2025
GA-ASI Adds Saab Airborne Early Warning Capability to MQ-9B
Jun 17, 2025
GKN Aerospace Secures Five-Year Repair Contract Extension with Pratt &...
Jun 17, 2025
DIEHL DEFENCE and HENSOLDT develop top-class software-defined air defence...
Jun 16, 2025
Portugal announces decision to acquire sixth KC-390 Millennium aircraft and...